Nicholas Piramal India: Survival Strategies for International Patent Law Regime



IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed

Code : COM0034

Year :
2004

Industry : Health Care

Region : USA India

Teaching Note:Not Available

Structured Assignment :Not Available

Buy This Case Study        

<< Previous

The Indian Pharmaceutical Industry Until the late 1960s, public sector firms such as Hindustan Antibiotics Ltd. and Indian Drugs and Pharmaceutical Ltd. and a host of global companies dominated the Indian pharmaceutical industry. 90% of the industry was dominated by the global companies that imported most of the drugs...

Evolution of Nicholas Piramal Nicholas Piramal India Limited (NPIL) was one of the largest pharmaceutical and healthcare companies in India that operated in cardio-vascular, antibiotics&respiratory, painmanagement, neuro-psychiatry and anti-diabetics segments...

NPIL’s Business Strategy NPIL had developed a business model which was built onmanufacturing, marketing, brand building, R&D and Human Resource. NPIL was a strong believer of "May I be the Highest, having gained your strengths in war, your skill in peace: my feet have trodden on your heads – Rig Veda". So, the company adopted the policy of merger and acquisition, alliances and JVs with those companies which could add value to its core business...

For Case Books Click Here >>

For Case eBooks Click Here >>

Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
Mob: +91- 9640901313,
E-mail: casehelpdesk@ibsindia.org

©2020-2025 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap